Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation

8 Jul 2016

Abstract excerpt

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for young Hurler patients. Despite halting of neurocognitive decline and improvement of life expectancy, the beneficial effect on the skeletal system is limited. As orthopedic complications are one of the most disabling factors following HSCT, this points to the need for new treatment strategies. The study summarizes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Glycogen Storage Diseases and Myoclonus
Share to Lysosomal Storage Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27392569
DOI: 10.1186/s13023-016-0470-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantationPMID 27392569Read ↗

Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndromeSemantic proximity Read ↗

Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedureSemantic proximity Read ↗

MPSI Manifestations and Treatment Outcome: Skeletal Focus.Semantic proximity Read ↗

Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis IISemantic proximity Read ↗

Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and FutureSemantic proximity Read ↗

Updates in Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative ReviewSemantic proximity Read ↗

Long term follow-up after haematopoietic stem cell transplantation for mucopolysaccharidosis type I-H: a retrospective study of 51 patientsSemantic proximity Read ↗

Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.Semantic proximity Read ↗

MPS I: Early diagnosis, bone disease and treatment, where are we now?Semantic proximity Read ↗

Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment statusSemantic proximity Read ↗

Best practice guidelines in managing the craniofacial aspects of skeletal dysplasiaSemantic proximity Read ↗

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.